Title
MPT64 patch test for the diagnosis of active pulmonary tuberculosis: A randomised controlled trial in Peru
Date Issued
01 June 2018
Access level
open access
Resource Type
journal article
Author(s)
Publisher(s)
International Union against Tubercul. and Lung Dis.
Abstract
Setting: There remains a lack of effective and inexpensive diagnostic tools for active tuberculosis (TB) disease. Testing immune responses to proteins secreted by Mycobacterium tuberculosis, such as MPT64, may be a diagnostic option. Objective: To evaluate the sensitivity and specificity of a patch test using MPT64 for the diagnosis of active TB disease. Design: This randomised, double-blind, placebo-controlled, prospective study in Lima, Peru, involved 55 healthy controls and 457 symptomatic individuals referred for routine TB testing by the National TB Control Programme. All subjects underwent a comprehensive diagnostic workup, and received an active patch on one arm and a placebo patch on the opposite arm, which were read after 4 days. Results: Eighty-one (18%) of the symptomatic participants were classified as having definite TB, while an additional 98 (21%) had probable TB. The patch tests performed the same in both groups, with a sensitivity of 27% and specificity of 74%. The area under the receiver operating characteristic curve was 0.495 (95%CI 0.425-0.565). Conclusions: Contrary to existing literature, the MPT64 patch was not sensitive and specific to detect active TB. Given the potential of the test, understanding possible differences in the protein source or underlying genetic factors should be explored further.
Start page
622
End page
627
Volume
22
Issue
6
Language
English
OCDE Knowledge area
Enfermedades infecciosas Sistema respiratorio Tecnología médica de laboratorio (análisis de muestras, tecnologías para el diagnóstico)
Scopus EID
2-s2.0-85046976656
PubMed ID
Source
International Journal of Tuberculosis and Lung Disease
ISSN of the container
10273719
Sponsor(s)
The authors thank their tireless team of research nurses: B Castro Cueto, R Gutierrez, F Garcia Velarde, V Huancare Pusari, M Huayta Guevara, R Limassca Zorrilla, J Rodriguez Oncoy, E Guadalupe Soto Napa; M P Navarro Mendizabal for laboratory support; C Solis for transportation support; K Peru for trial monitoring; M E Talledo Furlong and J Zeuner; Quintiles for monitoring support; E Venturi and P Toralva; and L Caviedes, taken from us prematurely but forever an inspiration; C Salazar Gonzales (Lima Este) and S Suarez Guimarey (Lima Sur) for help with local review and approval; and D Juanito for nutritional support. The cooperation and assistance of the staff of the following health care establishments was crucial to the success of study execution, for which we are very grateful: Centro de Deporte y Salud, Fortaleza, CS Nocheto, Hospital Huaycan, CS El Exito (Dirección de Servicios de Salud [DISA] Lima Este, Peru), José Carlos Mariátegui, Centro Médico Internacional San Jose (DISA Lima Sur). DAJM received support from the Wellcome Trust, London, UK (078067/Z/05/Z). Conflicts of interest: none declared.
Sources of information: Directorio de Producción Científica Scopus